Your browser doesn't support javascript.
loading
Comparing the Benefit of Duplex Ultrasound Surveillance Following Both Infrainguinal Bypass Surgery and Stenting for Femoro-Popliteal Disease.
Dar, Than; Li, Lanxin; Basra, Melvinder; Crockett, Stephen; Chowdhury, Mohammed M; Zielinski, Lukasz Piotr; Ambler, Graeme K; Coughlin, Patrick A.
Affiliation
  • Dar T; University of Cambridge, Cambridge, UK.
  • Li L; University of Cambridge, Cambridge, UK.
  • Basra M; Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Crockett S; Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Chowdhury MM; Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Zielinski LP; Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Ambler GK; Department of Vascular Surgery, Bristol Royal Infirmary, UK.
  • Coughlin PA; Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Vasc Endovascular Surg ; 57(1): 11-18, 2023 Jan.
Article in En | MEDLINE | ID: mdl-35972881
ABSTRACT

OBJECTIVE:

Duplex ultrasound surveillance (DUS) is commonly used following infrainguinal vein bypass. The role of DUS following endovascular revascularisation is as yet unclear. This study focuses on the role of DUS in a contemporary group of patients undergoing infrainguinal bypass or stent insertion.

METHODS:

All patients undergoing either an infrainguinal vein graft bypass or stent insertion into the femoro-popliteal segment (November 2014 - January 2017) were identified. Patients were followed up for 2 years. Data on entry into DUS, pre-operative characteristics, adjunctive pharmacotherapy and reintervention were collated. The primary outcomes were major lower limb amputation and mortality at 2 years post revascularisation.

RESULTS:

One hundred and thirty-five patients underwent infrainguinal vein bypass and 100 patients underwent stent insertion. 107 patients in the bypass cohort and 58 patients in the stent cohort entered DUS. For the bypass cohort, entering DUS was associated with a lower mortality rate (P = .003) but was not associated with an improvement in amputation rates. The odds ratio of major amputation or mortality was greater in the no surveillance group (4.58, 95% CI 1.855 - 11.364). In the stent cohort, DUS was not associated with a significant improvement in either major amputation or death (odds ratio 2.13 (95% CI 0.903 - 5.051; P = .081).

CONCLUSION:

DUS was associated with improved survival rates in patients undergoing lower limb bypass but had no benefit in those patients undergoing stent insertion. The role of DUS following stent insertion in the femoropopliteal segment needs to be better defined.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Surgical Procedures / Femoral Artery Limits: Humans Language: En Journal: Vasc Endovascular Surg Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Surgical Procedures / Femoral Artery Limits: Humans Language: En Journal: Vasc Endovascular Surg Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: United kingdom
...